Skip to main content

MoneyWorks4Me

Zydus Lifesciences informs about press release

27 Nov 2025 Evaluate

Zydus Lifesciences has informed that it enclosed press release titled ‘Zydus receives tentative approval from USFDA for Empagliflozin and Linagliptin Tablets, 10 mg/5 mg and 25 mg/5 mg.’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1913.40
Dr. Reddys Labs. 1384.25
Cipla 1412.00
Lupin 2016.00
Zydus Lifesciences 1221.35
View more..